• A Win for Migraine Patients: Increased Access for New Targeted Therapies

  • Jul 18 2024
  • Duración: 21 m
  • Podcast

A Win for Migraine Patients: Increased Access for New Targeted Therapies Por arte de portada

A Win for Migraine Patients: Increased Access for New Targeted Therapies

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this special episode of Talking Head Pain, Joe is joined by renowned headache specialists Dr. Tepper and Dr. Ailani to discuss a groundbreaking shift in migraine treatment accessibility. They delve into the recent endorsement by the American Headache Society of calcitonin gene-related peptide (CGRP) blockers as the primary preventive treatment for migraines, a move that promises to simplify the patient's journey toward relief.

    This discussion explores the implications for insurance and pharmacy benefit managers practices and patient care, providing hope and actionable advice for those living with migraine.

    Contact Our Hosts:

    Joe Coe, Chief Value, Growth, and Therapeutic Solutions Officer, Country Manager, Canada at GHLF: jcoe@ghlf.org

    Sarah Shaw, Associate Director, Diversity, Equity and Inclusion at GHLF: sshaw@ghlf.org

    A podcast episode produced by Ben Blanc, Associate Director, Digital Production and Engagement at GHLF.

    We want to hear what you think. Send your comments, or a video or audio clip of yourself, to podcasts@ghlf.org

    Catch up on all our episodes on our website or on your favorite podcast channel.

    See omnystudio.com/listener for privacy information.
    Más Menos
activate_primeday_promo_in_buybox_DT
Hygiene & Healthy Living
Más Menos

Lo que los oyentes dicen sobre A Win for Migraine Patients: Increased Access for New Targeted Therapies

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles